AFP and hepatoblastoma: Liuet al. [59] developed a magnetic bead separation platform consisting of a switching aptamer-triggered hybridization chain reaction (SAT-HCR) and the CRISPR-Cas12a sensor for alpha fetoprotein (AFP), a marker of hepatoblastoma.